Nov 11, 2020 / 07:45PM GMT
Jailendra P. Singh - Crédit Suisse AG - Research Division - Research Analyst
All right. We'll get started. Hello, everyone. I'm Jailendra Singh, healthcare technology and distribution analyst at Crédit Suisse. Thanks, everyone, for joining us. Next up, we have Teladoc Health. From the company, we have Jason Gorevic, CEO; Mala Murthy, CFO; and Patrick Feeley, VP of IR. We are going to do this as a fireside chat. I have some prepared questions, which I plan to cover. We will then open the line for Q&A. And if you want to me to ask a question on your behalf, please e-mail them to me at [email protected].
Questions and Answers:
Jailendra P. Singh - Crédit Suisse AG - Research Division - Research AnalystThanks, Jason, Mala and Patrick for doing this. I really appreciate that. And I saw the guidance update last night for Livongo deal. So making it completely formal. The deal is closed now. That's good. Congratulations on that. Maybe if you can begin with the sharing some thoughts around